Immunic to Participate in Scientific and Investor Conferences in March
Press Releases
March 3, 2025

Immunic to Participate in Scientific and Investor Conferences in March

NEW YORK, March 3, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

bradford

The Bradford Era

More by this Author
Local & Social